Wednesday, April 27, 2016 10:27:52 PM
Chemically, the members of this class are derivatives of the parent compound thiazolidinedione, and include:
Pioglitazone (Actos), France and Germany have suspended its sale after a study suggested the drug could raise the risk of bladder cancer.[4]
Rosiglitazone (Avandia), which was put under selling restrictions in the US and withdrawn from the market in Europe due to some studies suggesting an increased risk of cardiovascular events. Upon re-evaluation of new data in 2013, the FDA lifted the restrictions.
Lobeglitazone (Duvie), approved for use in Korea
Troglitazone (Rezulin), which was withdrawn from the market due to an increased incidence of drug-induced hepatitis.
As for other classes, Metformin is a poor choice in renal insufficiency, a common condition found with diabetes. Other oral type 2 meds have side effects of weight gain and lose effectiveness with time and increased use.
Sucanon, in published studies, ("substantial clinical investigations" in the FDAs words), shows weight loss, decrease in visceral body fat and improved lipid profiles, and no reported adverse side effects.
Excellent insight, and in no way a ridiculous comment. It really is a shame to ridicule what we don't understand.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM